OMNIAB INC (OABI) Fundamental Analysis & Valuation

NASDAQ:OABI • US68218J1034

Current stock price

1.5 USD
-0.02 (-1.32%)
Last:

This OABI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OABI Profitability Analysis

1.1 Basic Checks

  • In the past year OABI has reported negative net income.
  • In the past year OABI has reported a negative cash flow from operations.
  • In the past 5 years OABI always reported negative net income.
  • OABI had negative operating cash flow in 4 of the past 5 years.
OABI Yearly Net Income VS EBIT VS OCF VS FCFOABI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • OABI has a Return On Assets of -21.53%. This is in the lower half of the industry: OABI underperforms 66.67% of its industry peers.
  • OABI's Return On Equity of -24.26% is in line compared to the rest of the industry. OABI outperforms 47.37% of its industry peers.
Industry RankSector Rank
ROA -21.53%
ROE -24.26%
ROIC N/A
ROA(3y)-18.02%
ROA(5y)-13.65%
ROE(3y)-20.64%
ROE(5y)-16%
ROIC(3y)N/A
ROIC(5y)N/A
OABI Yearly ROA, ROE, ROICOABI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20

1.3 Margins

  • OABI has a Gross Margin of 98.38%. This is amongst the best in the industry. OABI outperforms 100.00% of its industry peers.
  • OABI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OABI Yearly Profit, Operating, Gross MarginsOABI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. OABI Health Analysis

2.1 Basic Checks

  • OABI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OABI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for OABI has been increased compared to 5 years ago.
  • There is no outstanding debt for OABI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OABI Yearly Shares OutstandingOABI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M
OABI Yearly Total Debt VS Total AssetsOABI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.59 indicates that OABI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • OABI's Altman-Z score of 2.59 is fine compared to the rest of the industry. OABI outperforms 63.16% of its industry peers.
  • There is no outstanding debt for OABI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACCN/A
WACC10.92%
OABI Yearly LT Debt VS Equity VS FCFOABI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.02 indicates that OABI has no problem at all paying its short term obligations.
  • The Current ratio of OABI (4.02) is better than 68.42% of its industry peers.
  • OABI has a Quick Ratio of 3.97. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 3.97, OABI is doing good in the industry, outperforming 71.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.02
Quick Ratio 3.97
OABI Yearly Current Assets VS Current LiabilitesOABI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OABI Growth Analysis

3.1 Past

  • OABI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.00%.
  • OABI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.27%.
  • Measured over the past years, OABI shows a decrease in Revenue. The Revenue has been decreasing by -4.31% on average per year.
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)-29.27%
Revenue growth 3Y-31.89%
Revenue growth 5Y-4.31%
Sales Q2Q%-22.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.24% on average over the next years. This is quite good.
  • Based on estimates for the next years, OABI will show a very strong growth in Revenue. The Revenue will grow by 41.01% on average per year.
EPS Next Y29.32%
EPS Next 2Y19.62%
EPS Next 3Y17.55%
EPS Next 5Y17.24%
Revenue Next Year44.88%
Revenue Next 2Y54.47%
Revenue Next 3Y46.15%
Revenue Next 5Y41.01%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OABI Yearly Revenue VS EstimatesOABI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
OABI Yearly EPS VS EstimatesOABI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. OABI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OABI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OABI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OABI Price Earnings VS Forward Price EarningsOABI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OABI Per share dataOABI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OABI's earnings are expected to grow with 17.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.62%
EPS Next 3Y17.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OABI Dividend Analysis

5.1 Amount

  • OABI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OABI Fundamentals: All Metrics, Ratios and Statistics

OMNIAB INC

NASDAQ:OABI (4/9/2026, 11:10:24 AM)

1.5

-0.02 (-1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners40.73%
Inst Owner Change0%
Ins Owners6.77%
Ins Owner Change2.78%
Market Cap217.17M
Revenue(TTM)18.67M
Net Income(TTM)-64.78M
Analysts84.62
Price Target7.48 (398.67%)
Short Float %5.28%
Short Ratio15.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.9%
Min EPS beat(2)-21.76%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-4.27%
Min EPS beat(4)-21.76%
Max EPS beat(4)4.35%
EPS beat(8)3
Avg EPS beat(8)-3.3%
EPS beat(12)4
Avg EPS beat(12)-16.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-34.95%
Min Revenue beat(2)-61.11%
Max Revenue beat(2)-8.79%
Revenue beat(4)0
Avg Revenue beat(4)-26.88%
Min Revenue beat(4)-61.11%
Max Revenue beat(4)-8.79%
Revenue beat(8)2
Avg Revenue beat(8)-20.16%
Revenue beat(12)2
Avg Revenue beat(12)-24.94%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.35%
Revenue NQ rev (3m)-3.35%
Revenue NY rev (1m)-12.82%
Revenue NY rev (3m)-12.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.63
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 3.75
EV/EBITDA N/A
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.13
BVpS1.84
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.53%
ROE -24.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.38%
FCFM N/A
ROA(3y)-18.02%
ROA(5y)-13.65%
ROE(3y)-20.64%
ROE(5y)-16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.6%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.02
Quick Ratio 3.97
Altman-Z 2.59
F-Score2
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)6.33%
Cap/Depr(5y)27.62%
Cap/Sales(3y)4.98%
Cap/Sales(5y)11.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y29.32%
EPS Next 2Y19.62%
EPS Next 3Y17.55%
EPS Next 5Y17.24%
Revenue 1Y (TTM)-29.27%
Revenue growth 3Y-31.89%
Revenue growth 5Y-4.31%
Sales Q2Q%-22.47%
Revenue Next Year44.88%
Revenue Next 2Y54.47%
Revenue Next 3Y46.15%
Revenue Next 5Y41.01%
EBIT growth 1Y3.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.09%
OCF growth 3YN/A
OCF growth 5YN/A

OMNIAB INC / OABI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OMNIAB INC (OABI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to OABI.


What is the valuation status of OMNIAB INC (OABI) stock?

ChartMill assigns a valuation rating of 0 / 10 to OMNIAB INC (OABI). This can be considered as Overvalued.


Can you provide the profitability details for OMNIAB INC?

OMNIAB INC (OABI) has a profitability rating of 1 / 10.